Nevro (NYSE:NVRO) : Wednesdays money flow data in Nevro (NYSE:NVRO) suggests that the bulls made the most of the weakness in the stock. The inflow of money into the stock on upticks was $1.39 million, whereas, $0.22 million worth of transactions were done on downticks. The ratio between the two, uptick and downtick stood at 6.39, in favor of the bulls. The total money flow into the stock was $1.17 million clearly indicating that the smart money has been buying into the stock on weakness.
In comparison, the money flow in block deals was $0.95 million. The total value of block trades done on upticks was $0.95 million. Nevro (NYSE:NVRO) fell $0.2 and traded at $69.68, down -0.28% for the day, over previous days close. On a weekly basis, the shares are -1.14% over the previous weeks close.
In an insider trading activity, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the officer (Senior VP,Research&Development) of Nevro Corp, Walker Andre had sold 6,000 shares worth of $456,000 in a transaction dated June 8, 2016. In this transaction, 6,000 shares were sold at $76 per share. Currently the company Insiders own 12.1% of Nevro shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -54.51% . Institutional Investors own 96.99% of Nevro shares. During last six month period, the net percent change held by insiders has seen a change of -94.21%.
The company shares have rallied 29.80% from its 1 Year high price. On Jun 8, 2016, the shares registered one year high at $77.94 and the one year low was seen on Oct 22, 2015. The 50-Day Moving Average price is $69.70 and the 200 Day Moving Average price is recorded at $63.70. Nevro (NYSE:NVRO): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $71.06 and $69.41 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $72.45. The buying momentum continued till the end and the stock did not give up its gains. It closed at $71.69, notching a gain of 2.60% for the day. The total traded volume was 347,458 . The stock had closed at $69.87 on the previous day.
Nevro Corp. is a medical device company. The Company manufactures and markets active implantable medical devices for the treatment of neurological disorders initially focusing on the treatment of chronic pain. The Company developed and commercialized a neuromodulation platform for the treatment of chronic pain. The Companys Senza system is the only spinal cord stimulation (SCS) system that delivers its HF10 therapy. The Companys Senza system creates electrical impulses from two hertz to 10 kilohertz, including its HF10 therapy, which allows for pain relief without paresthesia. HF10 therapy delivers waveforms at 10 kilohertz pulse rate with a statistically driven and clinically verified programming algorithm. Senza consists of leads, a trial stimulator, an implantable pulse generator (IPG), surgical tools, a clinician laptop programmer, a patient remote control and a mobile charger.